Antiviral antibody responses: the two extremes of a wide spectrum (Q36405084)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article

Language	Label	Description	Also known as
English	Antiviral antibody responses: the two extremes of a wide spectrum	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

1 reference

Europe PubMed Central

Antiviral antibody responses: the two extremes of a wide spectrum (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

1 reference

based on heuristic

inferred from title

Rolf M. Zinkernagel

2

object named as

Rolf M Zinkernagel

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

author name string

Lars Hangartner

1

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Hans Hengartner

3

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

publication date

1 March 2006

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Nature Reviews Immunology

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

231-243

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

A pox on thee! Manipulation of the host immune system by myxoma virus and implications for viral-host co-adaptation

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

THE EPIDEMIOLOGY OF LYMPHOCYTIC CHORIOMENINGITIS IN WHITE MICE.

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Hepatitis B virus infection in children

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Human papillomavirus life cycle: active and latent phases

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

The role of antibody concentration and avidity in antiviral protection.

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Neutralizing antibody to human rhinovirus 14 penetrates the receptor-binding canyon.

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Structure of influenza virus haemagglutinin complexed with a neutralizing antibody.

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

A complex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptor binding site

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

HIV entry and its inhibition

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

IgG neutralization of type A influenza viruses and the inhibition of the endosomal fusion stage of the infectious pathway in BHK cells

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Antibody response of patients with severe acute respiratory syndrome (SARS) targets the viral nucleocapsid

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

The interaction of antibody with the major surface glycoprotein of vesicular stornatitis virus II. Monoclonal antibodies to nonneutralizing and cross-reactive epitopes of Indiana and New Jersey serotypes

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Antibody response of mice to lactate dehydrogenase-elevating virus during infection and immunization with inactivated virus.

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Antibody neutralization and escape by HIV-1

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Rapid evolution of the neutralizing antibody response to HIV type 1 infection

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

The interaction of antibody with the major surface glycoprotein of vesicular stomatitis virus I. Analysis of neutralizing epitopes with monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Structure of a human common cold virus and functional relationship to other picornaviruses

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Hyperglycosylated Mutants of Human Immunodeficiency Virus (HIV) Type 1 Monomeric gp120 as Novel Antigens for HIV Vaccine Design

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Neutralizing epitopes of lymphocytic choriomeningitis virus are conformational and require both glycosylation and disulfide bonds for expression

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Kinetics of protective antibodies are determined by the viral surface antigen

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Antiviral immune responses in gene-targeted mice expressing the immunoglobulin heavy chain of virus-neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Innate and acquired humoral immunities to influenza virus are mediated by distinct arms of the immune system

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Natural antibodies and complement link innate and acquired immunity

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Fc alpha/mu receptor mediates endocytosis of IgM-coated microbes

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Dual antigen recognition by B cells

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Recombinant vesicular stomatitis (Indiana) virus expressing New Jersey and Indiana glycoproteins induces neutralizing antibodies to each serotype in swine, a natural host

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Role of IgM antibodies versus B cells in influenza virus-specific immunity

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Dual role of B cells in mediating innate and acquired immunity to herpes simplex virus infections

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Paralytic poliomyelitis caused by a vaccine-derived polio virus in an antibody-deficient Argentinean child

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Cooperation of B cells and T cells is required for survival of mice infected with vesicular stomatitis virus

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

A Critical Role for Induced IgM in the Protection against West Nile Virus Infection

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

IgD can largely substitute for loss of IgM function in B cells

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Influenza virus: a novel method to assess viral and neutralizing antibody titers in vitro

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

T-cell independent IgM and enduring protective IgG antibodies induced by chimeric measles viruses

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Adaptation to promiscuous usage of chemokine receptors is not a prerequisite for human immunodeficiency virus type 1 disease progression

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Deliberate removal of T cell help improves virus-neutralizing antibody production.

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Induction of long-lived germinal centers associated with persisting antigen after viral infection

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Natural human antibodies retrieved by phage display libraries from healthy donors: polyreactivity and recognition of human immunodeficiency virus type 1gp120 epitopes.

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Mapping the B cell superantigen binding site for HIV-1 gp120 on a V(H)3 Ig.

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

HIV infection rapidly induces and maintains a substantial suppression of thymocyte proliferation.

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Plasma cells for a lifetime?

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals.

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

CD4(+) T cell-mediated protection against a lethal outcome of systemic infection with vesicular stomatitis virus requires CD40 ligand expression, but not IFN-gamma or IL-4.

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

A critical role for neutralizing-antibody-producing B cells, CD4(+) T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

IgG2a restriction of murine antibodies elicited by viral infections

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Analysis of the virus-specific and nonspecific B cell response to a persistent B-lymphotropic gammaherpesvirus

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

CD4(+) T cell subsets during virus infection. Protective capacity depends on effector cytokine secretion and on migratory capability

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Epitopes involved in antibody-mediated protection from Ebola virus

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Increased efficacy of the immunoglobulin G2a subclass in antibody-mediated protection against lactate dehydrogenase-elevating virus-induced polioencephalomyelitis revealed with switch mutants

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Monoclonal antibodies to the matrix (E1) glycoprotein of mouse hepatitis virus protect mice from encephalitis

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Unmutated immunoglobulin M can protect mice from death by influenza virus infection

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Induction of protective cytotoxic T cell responses in the presence of high titers of virus-neutralizing antibodies: implications for passive and active immunization

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

On natural and artificial vaccinations

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys.

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Antibody response to pre-S2 and hepatitis B virus induced liver damage

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus (HBV) envelope (env) protein are virus-neutralizing and protective

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Antibodies, viruses and vaccines

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

The role of somatic mutation in the generation of the protective humoral immune response against vesicular stomatitis virus.

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Somatic mutations can lead to a loss of superantigenic and polyreactive binding

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Viral persistence in vivo through selection of neutralizing antibody-escape variants.

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Public versus personal serotypes of a viral quasispecies.

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Additive effect of neutralizing antibody and antiviral drug treatment in preventing virus escape and persistence

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Susceptibility to lymphocytic choriomeningitis virus isolates correlates directly with early and high cytotoxic T cell activity, as well as with footpad swelling reaction, and all three are regulated by H-2D

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Lymphocytic choriomeningitis virus. VI. Isolation of a glycoprotein mediating neutralization

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Viral escape from the neutralizing antibody response: the lymphocytic choriomeningitis virus model.

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Protective long-term antibody memory by antigen-driven and T help-dependent differentiation of long-lived memory B cells to short-lived plasma cells independent of secondary lymphoid organs

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Somatic mutation and the maturation of immune response to 2-phenyl oxazolone

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Thymus dependence of viral antigens

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

21 January 2018

Herpes simplex viruses

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

31 March 2020

Functional role of type I and type II interferons in antiviral defense

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

31 March 2020

Early high-affinity neutralizing anti-viral IgG responses without further overall improvements of affinity

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

31 March 2020

Class I and class II viral fusion protein structures reveal similar principles in membrane fusion

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

31 March 2020

Enhancement of disease by neutralizing antiviral antibodies in the absence of primed antiviral cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

31 March 2020

HIV-1 antibody--debris or virion?

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

31 March 2020

A synthetic peptide ELISA for the screening of rubella virus neutralizing antibodies in order to ascertain immunity

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

31 March 2020

Neutralization activity and persistence of antibodies induced in response to vaccination with a novel mumps strain, RIT 4385

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

31 March 2020

Development of the antibody response in acute HIV-1 infection

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

31 March 2020

Molecular determinants of immunogenicity: the immunon model of immune response

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

31 March 2020

The repertoire of serum IgM in normal mice is largely independent of external antigenic contact

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

31 March 2020

Molecular analysis of HIV-1 gp120 antibody response using isotype IgM and IgG phage display libraries from a long-term non-progressor HIV-1-infected individual

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

31 March 2020

Correlation of T cell independence of antibody responses with antigen dose reaching secondary lymphoid organs: implications for splenectomized patients and vaccine design

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

31 March 2020

Control of early viral and bacterial distribution and disease by natural antibodies

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

31 March 2020

Crucial role of marginal zone macrophages and marginal zone metallophils in the clearance of lymphocytic choriomeningitis virus infection

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

31 March 2020

Marginal zone macrophages and immune responses against viruses

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

31 March 2020

Immunity to viruses in B cell-deficient mice: influence of antibodies on virus persistence and on T cell memory

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

31 March 2020

T-cell-independent antiviral antibody responses

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

31 March 2020

Replication of HIV-1 in dendritic cell-derived syncytia at the mucosal surface of the adenoid

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

31 March 2020

Hypergammaglobulinemia and autoantibody induction mechanisms in viral infections

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

31 March 2020

Virus-triggered acquired immunodeficiency by cytotoxic T-cell-dependent destruction of antigen-presenting cells and lymph follicle structure

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

31 March 2020

An acquired immune suppression in mice caused by infection with lymphocytic choriomeningitis virus

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

31 March 2020

Structure of the VH and VL segments of polyreactive and monoreactive human natural antibodies to HIV-1 and Escherichia coli beta-galactosidase

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

31 March 2020

The half-lives of serum immunoglobulins in adult mice.

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

31 March 2020

Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

31 March 2020

Reinfection of mice with respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

31 March 2020

Immunological memory and protective immunity: understanding their relation

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

31 March 2020

Immunologic correlates of protection induced by vaccination

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

31 March 2020

Immunology of hepatitis B infection

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

31 March 2020

Accumulation of somatic mutants in the B cell compartment after primary immunization with a T cell-dependent antigen

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

31 March 2020

Disquisitions of Original Antigenic Sin. I. Evidence in man

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

31 March 2020

Ebola virus can be effectively neutralized by antibody produced in natural human infection

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

7 January 2021

based on heuristic

inferred from DOI database lookup

Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

7 January 2021

based on heuristic

inferred from DOI database lookup

Virus-induced immunosuppression: immune system-mediated destruction of virus-infected dendritic cells results in generalized immune suppression.

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

7 January 2021

based on heuristic

inferred from DOI database lookup

Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

7 January 2021

based on heuristic

inferred from DOI database lookup

Clearance of lymphocytic choriomeningitis virus in antibody- and B-cell-deprived mice

1 reference

https://api.crossref.org/works/10.1038%2FNRI1783

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanisms of antibody-mediated protection against lymphocytic choriomeningitis virus infection: mother-to-baby transfer of humoral protection

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1038/NRI1783

Identifiers

10.1038/NRI1783

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36405084&oldid=2198841574"